ifenprodil has been researched along with phenol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begrow, F; Falck, E; Verspohl, E; Wünsch, B | 1 |
| Begrow, F; Falck, E; Verspohl, EJ; Wünsch, B | 1 |
| Ametamey, SM; Börgel, F; Galla, F; Lehmkuhl, K; Schepmann, D; Wünsch, B | 1 |
3 other study(ies) available for ifenprodil and phenol
| Article | Year |
|---|---|
Metabolism studies of ifenprodil, a potent GluN2B receptor antagonist.
Topics: Animals; Binding Sites; Biological Availability; Biotransformation; Cattle; Chromatography, Liquid; Female; Male; Mass Spectrometry; Microsomes, Liver; Phenol; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serum Albumin | 2014 |
In vitro and in vivo biotransformation of WMS-1410, a potent GluN2B selective NMDA receptor antagonist.
Topics: Animals; Benzazepines; Biotransformation; Catechols; Hydroxylation; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Microsomes, Liver; Phenol; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2014 |
Pharmacokinetic properties of enantiomerically pure GluN2B selective NMDA receptor antagonists with 3-benzazepine scaffold.
Topics: Animals; Benzazepines; Biotransformation; Glucuronides; Humans; Mice; Mice, Inbred C57BL; Microsomes, Liver; Phenol; Piperidines; Protein Binding; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Stereoisomerism; Structure-Activity Relationship | 2019 |